Boyds, MD, United States of America

Likan Liang

This inventor holds 26 USPTO granted patents and 7 published patent applications, plus 8 CIPO patents and 9 EPO patents, primarily in CNS Formulations. Top assignees: Supernus Pharmaceuticals, Inc., Soligenix, Inc.. Active years: 2012-2021.

USPTO Granted Patents = 26 

% Patents Active = 92.3

 

 

Average Co-Inventor Count = 4.8

ph-index = 4

Forward Citations = 172(Granted Patents)


Company Filing History:


Years Active: 2012-2021

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
CNS Compounds
Sustained-Release
Topiramate
Viloxazine
Molindone
Polymorphs
Controlled Release
Stabilized Formulations
Gamma-Hydroxybutyrate
Reverse Micelle
Formulations
26 patents (USPTO):Explore Patents

Title: The Innovations of Likan Liang: A Journey Through Patents and Collaborations

Introduction: Likan Liang, a prolific inventor based in Boyds, MD, has contributed significantly to the fields of pharmaceuticals and chemistry through his groundbreaking inventions. With an impressive portfolio of 26 patents, his work focuses primarily on the synthesis and stabilization of medicinal compounds, particularly molindone, a drug used in treating certain mental health disorders.

Latest Patents: Among his latest patents, Likan has developed novel methods for producing molindone and its salts. His invention is aimed at creating efficient synthesis methods for molindone, including the synthesis of its intermediates and ensuring high-purity compositions. Specifically, he applies the Mannich reaction in his approach. Furthermore, he has advanced stabilized formulations of central nervous system (CNS) compounds, detailing formulations of molindone that boast superior stability and various methods for administering these formulations, which may include immediate, modified, or delayed-release options.

Career Highlights: Likan Liang has held positions with renowned pharmaceutical companies such as Supernus Pharmaceuticals, Inc. and Soligenix, Inc. His work in these organizations has allowed him to innovate within a collaborative environment, enhancing the development of effective therapeutic solutions.

Collaborations: Throughout his career, Likan has partnered with esteemed colleagues like Padmanabh P. Bhatt and Michael L. Vieira. These collaborations have been instrumental in refining his ideas and bringing his inventions to fruition, demonstrating the importance of teamwork in the innovative process.

Conclusion: Likan Liang's contributions to pharmaceutical sciences, particularly through his extensive patent portfolio, reflect a dedication to innovation and improvement in therapeutic formulations. His research and collaborative efforts continue to pave the way for advancements in medical treatments, highlighting the critical role of inventors in driving progress in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…